EPHORAN Multi Imaging Solutions, a Contract Research Organization based in Italy, provides a complete solution toolset for non-invasive in vivo preclinical imaging to study, develop, and promote the application of imaging technologies in pre-clinical drug research and development.
EPHORAN offers in vivo imaging and pharmaco-toxicological testing services, using serial/longitudinal imaging experiments during pharmacology and toxicology animal studies.
Ephoran can provide preclinical imaging services covering all imaging techniques from those extensively used in clinical phases (e.g. MRI, PET, CT, SPECT, US, Opto-US) to Optical Imaging (OI, visible light and Near Infra Red – NIR), to assure a link between the preclinical and clinical studies.

Our facility is quipped with a 1, 3, ad 7T MRI imagers, hybrid PET/SPECT/CT and SPECT/PET imagers, ultrasound equipmet coupled to Photoacustic imaging system, bioluminescence, and fluorescence imaging instruments, along with radiochemistry and radiotherapy capabilities. For situation where one modality will not answer all your biological questions Ephoran is capable of combining funcional and anatomical data using a multimodal imaging system (PET/SPECT/CT system).

Our pre-clinical in vivo imaging systems offer solution for quantitation, deep tissue targeting, such as lung, heart, liver, kidney, GI, and brain in order to monitor and quantify in real time biological targets and pathways, giving a deeper understanding of the biology underlying disease mechanism and therapeutic response. Furthermore Ephoran provides a great variety of in vivo testing services including subcutaneous tumor models (xenograft tumor models), orthotopic tumor models, inflammation, CNS, hematoma, and others.